Obesity induces a phenotypic switch in adipose tissue macrophage polarization, Journal of Clinical Investigation, vol.117, issue.1, pp.175-184, 2007. ,
DOI : 10.1172/JCI29881
Fat and Beyond: The Diverse Biology of PPAR??, Annual Review of Biochemistry, vol.77, issue.1, pp.289-312, 2008. ,
DOI : 10.1146/annurev.biochem.77.061307.091829
Macrophage-specific PPAR?? controls alternative activation and improves insulin resistance, Nature, vol.292, issue.7148, pp.1116-1120, 2007. ,
DOI : 10.1038/nature05894
Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages, Circulation, vol.117, issue.6, pp.806-815, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.107.724096
URL : https://hal.archives-ouvertes.fr/inserm-00480230
Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors, Seminars in Cancer Biology, vol.14, issue.3, pp.155-160, 2004. ,
DOI : 10.1016/j.semcancer.2003.10.001
Exploring the full spectrum of macrophage activation, Nature Reviews Immunology, vol.117, issue.12, pp.958-969, 2008. ,
DOI : 10.1038/nri2448
Xerostomia, hyposalivation, and oral microbiota in type 2 diabetic patients: a preliminary study, J Med Assoc Thai, vol.92, issue.9, pp.1220-1228, 2009. ,
Serological evidence of infections and Type 2 diabetes: the Multiethnic Study of Atherosclerosis, Diabetic Medicine, vol.25, issue.2, pp.149-152, 2009. ,
DOI : 10.1111/j.1464-5491.2008.02632.x
Esophagitis caused by Candida guilliermondii in diabetes mellitus: first reported case, Med Mycol, pp.1-4, 2010. ,
Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients, J Assoc Physicians India, vol.50, pp.1013-1016, 2002. ,
Candidal overgrowth in diabetic patients: potential predisposing factors, Mycoses, vol.32, issue.3, pp.192-196, 2005. ,
DOI : 10.1016/0003-9969(80)90075-8
Diabetes mellitus as a contributory factor in oral candidosis, Diabetic Medicine, vol.10, issue.5, pp.455-459, 2006. ,
DOI : 10.1016/1056-8727(93)90025-T
PPAR?? Promotes Mannose Receptor Gene Expression in Murine Macrophages and Contributes to the Induction of This Receptor by IL-13, Immunity, vol.19, issue.3, pp.329-339, 2003. ,
DOI : 10.1016/S1074-7613(03)00229-2
IL-13 Attenuates Gastrointestinal Candidiasis in Normal and Immunodeficient RAG-2-/- Mice via Peroxisome Proliferator-Activated Receptor-?? Activation, The Journal of Immunology, vol.180, issue.7, pp.4939-4947, 2008. ,
DOI : 10.4049/jimmunol.180.7.4939
URL : https://hal.archives-ouvertes.fr/hal-00283071
PPAR?? Controls Dectin-1 Expression Required for Host Antifungal Defense against Candida albicans, PLoS Pathogens, vol.31, issue.1, p.1000714 ,
DOI : 10.1371/journal.ppat.1000714.g007
A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages, Journal of Antimicrobial Chemotherapy, vol.49, issue.5, pp.731-740, 2002. ,
DOI : 10.1093/jac/dkf011
IL-13 induces expression of CD36 in human monocytes through PPARgamma activation, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00166681
Peroxisome Proliferator-Activated Receptor (PPAR)-?? Positively Controls and PPAR?? Negatively Controls Cyclooxygenase-2 Expression in Rat Brain Astrocytes through a Convergence on PPAR??/?? via Mutual Control of PPAR Expression Levels, Molecular Pharmacology, vol.76, issue.2, pp.414-424, 2009. ,
DOI : 10.1124/mol.109.056010
Innate immunity, insulin resistance and type 2 diabetes, Trends in Endocrinology & Metabolism, vol.19, issue.1, pp.10-16, 2008. ,
DOI : 10.1016/j.tem.2007.10.004
Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet-Induced Obesity in Mice, Diabetes, vol.59, issue.5, pp.1171-81, 2010. ,
DOI : 10.2337/db09-1402
Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production, International Journal of Obesity, vol.18, issue.9, pp.31-1420, 2007. ,
DOI : 10.1038/sj.ijo.0803632
A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways, Journal of Biological Chemistry, vol.282, issue.48, pp.35279-92, 2007. ,
DOI : 10.1074/jbc.M706762200
Macrophage activation and polarization, Frontiers in Bioscience, vol.13, issue.13, pp.453-461, 2008. ,
DOI : 10.2741/2692
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents., Journal of Clinical Investigation, vol.97, issue.11, pp.2553-2561, 1996. ,
DOI : 10.1172/JCI118703
Genetic analysis of four novel peroxisome proliferator activated receptor-?? splice variants in monkey macrophages, Biochemical and Biophysical Research Communications, vol.293, issue.1, pp.274-283, 2002. ,
DOI : 10.1016/S0006-291X(02)00138-9
Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor ?? and nuclear factor-??B in macrophages, Immunology, vol.27, issue.3, pp.344-58, 2008. ,
DOI : 10.1111/j.1365-2567.2008.02849.x
Endotoxin downregulates peroxisome proliferator-activated receptor-?? via the increase in TNF-?? release, AJP: Regulatory, Integrative and Comparative Physiology, vol.294, issue.1, pp.84-92, 2008. ,
DOI : 10.1152/ajpregu.00340.2007
Nrf2-Regulated PPAR{gamma} Expression is Critical to Protection Against Acute Lung Injury in Mice, Am J Respir Crit Care Med, 2010. ,
The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy, Diabetes, vol.59, issue.4, pp.850-60, 2010. ,
DOI : 10.2337/db09-1342
The many faces of PPARgamma: anti-inflammatory by any means?, Immunobiology, vol.213, pp.9-10, 2008. ,
Peroxisome proliferator-activated receptor-alpha (PPAR??): At the crossroads of obesity, diabetes and cardiovascular disease, Atherosclerosis, vol.205, issue.1, pp.1-8, 2009. ,
DOI : 10.1016/j.atherosclerosis.2009.03.008
Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit, J Immunol, vol.161, issue.11, pp.6198-6205, 1998. ,
Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications, Acta Diabetologica, vol.40, issue.1, pp.14-19, 2003. ,
DOI : 10.1007/s005920300003
Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus, Diabetes Research and Clinical Practice, vol.28, issue.2, pp.137-146, 1995. ,
DOI : 10.1016/0168-8227(95)00168-8
Relationship Between Inflammation, Insulin Resistance and Type 2 Diabetes: Cause or Effect?, Current Diabetes Reviews, vol.2, issue.2, pp.195-211, 2006. ,
DOI : 10.2174/157339906776818532
Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases, Chin Med J (Engl), vol.122, issue.18, pp.2123-2128, 2009. ,
Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet, Nutrition, vol.25, issue.7-8, pp.7-8, 2009. ,
DOI : 10.1016/j.nut.2008.12.010
Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes, Diabetologia, vol.278, issue.12, pp.2215-2225, 2004. ,
DOI : 10.1007/s00125-004-1581-6
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2, The Journal of Experimental Medicine, vol.63, issue.9, pp.1107-1117, 2003. ,
DOI : 10.1093/infdis/163.5.1154